With targeted resequencing, a subset of genes or regions of the genome are isolated and sequenced. Target enrichment works by capturing genomic regions of interest by hybridization to target-specific biotinylated probes, which are then isolated by magnetic pulldown.
Illumina DNA Prep with Enrichment is the latest innovation in next-generation sequencing (NGS) target enrichment solutions. By combining bead-linked transposome-mediated tagmentation chemistry with hybrid-capture target enrichment, researchers can reduce workflow time and produce an accurate, reliable assay for target enrichment resequencing.
Hybridization-based enrichment is a useful strategy for analyzing specific genetic variants in a given sample.
Target enrichment allows researchers the ability to reliably sequence exomes or large numbers of genes (e.g. > 50 genes) using robust and straightforward workflows. It delivers dependable results across a wide range of input types and quantities. Uses include:
Hybrid capture-based target enrichment lets researchers target regions of the genome that are relevant to their specific research interests. Targeted resequencing delivers higher discovery power (ability to identify novel variants), and higher mutation resolution than PCR or Sanger sequencing.
Compared to PCR-based amplicon sequencing, hybridization-based enrichment sequencing can target a higher amount of total gene content and support more comprehensive profiling of all variant types. The larger amount of total gene content allows for the characterization of both known and novel variants for discovery-related applications.
Target Enrichment |
Amplicon Sequencing |
Larger gene content, typically > 50 genes | Smaller gene content, typically < 50 genes |
More comprehensive profiling for all variant types | Ideal for analyzing single nucleotide variants and insertions/deletions (indels) |
More comprehensive method, but with longer hands-on time and turnaround time** | More affordable, easier workflow |
* Data on file, Illumina 2018.
** The turnaround time is for library prep assay time (DNA to finished library).
Illumina benchtop sequencing systems are making NGS technology more accessible to laboratories worldwide. Learn how these systems provide the speed, power, and flexibility to make breakthroughs in microbiology, cancer research, and more. The MiSeq i100 Series or NextSeq 1000 and NextSeq 2000 Systems can help make your NGS research goals within reach.
Download eBookHighly sensitive detection and characterization of common respiratory viruses, including SARS-CoV-2 and recent flu strains, with comprehensive, rapid target enrichment sequencing.
This NGS-based target enrichment workflow targets respiratory pathogens and antimicrobial resistance alleles, and offers simplified data analysis.
NGS is uniquely positioned in an infectious disease surveillance and outbreak model. Compare target enrichment with other pathogen NGS methods such as shotgun metagenomics. Find solutions to detect SARS-CoV-2, track transmission routes, study co-infection, and investigate viral evolution.
Array and NGS methods enable global genetic analyses to facilitate complex disease studies.
Learn MorePerform somatic variant profiling studies of tumor specimens.
Learn MoreInvestigate the protein-coding regions of the genome to uncover genetic influences on disease and population health.
Learn MoreAs a hypothesis-free method, NGS can distinguish between infectious disease strains that differ by as little as one SNP, and replace multiple tests.
Learn MoreCompare techniques for detecting single nucleotide polymorphisms and variants to determine which approach is best for your needs. Learn how scientists are accelerating the ability to link variants to function and gain valuable insights into disease biology.